Literature DB >> 16740556

Statistics and death from meningococcal disease in children.

Rafael Perera1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16740556      PMCID： PMC1473121          DOI： 10.1136/bmj.332.7553.1297

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Confounding and Simpson's paradox.

Authors:  S A Julious; M A Mullee
Journal:  BMJ       Date:  1994-12-03

2.  Early treatment with parenteral penicillin in meningococcal disease.

Authors:  K Cartwright; S Reilly; D White; J Stuart
Journal:  BMJ       Date:  1992-07-18

3.  Clinical recognition of meningococcal disease in children and adolescents.

Authors:  Matthew J Thompson; Nelly Ninis; Rafael Perera; Richard Mayon-White; Claire Phillips; Linda Bailey; Anthony Harnden; David Mant; Michael Levin
Journal:  Lancet       Date:  2006-02-04       Impact factor: 79.321

4.  Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study.

Authors:  Anthony Harnden; Nelly Ninis; Matthew Thompson; Rafael Perera; Michael Levin; David Mant; Richard Mayon-White
Journal:  BMJ       Date:  2006-03-22
  4 in total
  4 in total

Review 1.  Pre-admission antibiotics for suspected cases of meningococcal disease.

Authors:  Thambu D Sudarsanam; Priscilla Rupali; Prathap Tharyan; Ooriapadickal Cherian Abraham; Kurien Thomas
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

Review 2.  Challenging management dogma where evidence is non-existent, weak or outdated.

Authors:  Daniel A Hofmaenner; Mervyn Singer
Journal:  Intensive Care Med       Date:  2022-03-18       Impact factor: 41.787

Review 3.  Simpson's paradox and experimental research.

Authors:  Suzanne Ameringer; Ronald C Serlin; Sandra Ward
Journal:  Nurs Res       Date:  2009 Mar-Apr       Impact factor: 2.381

4.  Comparison of nebulized epinephrine to albuterol in bronchiolitis.

Authors:  Paul Walsh; John Caldwell; Kemedy K McQuillan; Steven Friese; Dale Robbins; Stephen J Rothenberg
Journal:  Acad Emerg Med       Date:  2008-04       Impact factor: 3.451
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.